- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Marksans Pharma's Board has re-appointed Mr. Mark Saldanha as Managing Director for a five-year term, effective October 6, 2025. This re-appointment awaits approval from shareholders at the forthcoming Annual General Meeting. Mr. Saldanha, with over two decades of experience, is recognized as the driving force behind the company's success and growth. His continued leadership is key for Marksans Pharma's strategic direction and performance going forward.